Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 3

Explainer

Can I buy TB-500 online legally?

TB-500 online purchase rules depend on the exact product and jurisdiction. US seller availability does not establish an approved pharmacy or import route.

15 Nov 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Does TB-500 cause muscle loss?

No direct human evidence shows that TB-500 causes or prevents muscle loss. Animal, cell and tirzepatide findings cannot answer the question.

15 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Is TB-500 safe during pregnancy?

TB-500 has not been shown safe in pregnancy. The only registered study excludes pregnancy, has no results, and there is no regulator-reviewed TB-500 label.

15 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tirzepatide kidney effects by endpoint

A parent-trial-level meta-analysis found lower albuminuria versus insulin, no clear fixed-time eGFR benefit, and outcome-dependent clinical signals.

15 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Can I buy BPC-157 online legally?

Online availability does not prove that a BPC-157 sale or import is legal. The answer depends on the product, seller, shipment, and jurisdiction.

14 Nov 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Is BPC-157 safe during pregnancy?

BPC-157 has not been shown safe in pregnancy. Human pregnancy evidence, approved prescribing information, and verified product-specific risk data are absent.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

GLP-1 Microdosing: Evidence and Risks

A 2026 Special Article defines GLP-1 microdosing, fractional dosing, and split dosing but reports no new clinical outcomes.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

GLP-1 evidence for pancreatic fat is mixed

A six-study systematic review found mixed human evidence on pancreatic fat, with no original participants and no semaglutide outcome data in people.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

What GLP-1 Travellers Manage Beyond Storage

A 2026 netnographic study maps the medicine logistics, eating changes and treatment workload described in 129 public travel discussions.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Semaglutide vs Tirzepatide CV Outcomes

A matched cohort found similar cardiovascular outcomes with semaglutide and tirzepatide, but the observational design cannot prove equivalence.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Semaglutide vs Tirzepatide Heart Risk

A claims-based target-trial emulation found no significant cardiovascular difference, but it cannot prove semaglutide and tirzepatide are equal.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tesamorelin metabolites persist in serum

A six-person administration study found tesamorelin metabolites in serum for up to two hours, while post-administration urine testing found none.

14 Nov 2026 · PeptideMethods Editorial Team · 4 min read